152 related articles for article (PubMed ID: 34409100)
1. Curcumin Inhibits Replication of Human Parainfluenza Virus Type 3 by Affecting Viral Inclusion Body Formation.
Zhang C; Zhang K; Zang G; Chen T; Lu N; Wang S; Zhang G
Biomed Res Int; 2021; 2021():1807293. PubMed ID: 34409100
[TBL] [Abstract][Full Text] [Related]
2. Inclusion Body Fusion of Human Parainfluenza Virus Type 3 Regulated by Acetylated α-Tubulin Enhances Viral Replication.
Zhang S; Jiang Y; Cheng Q; Zhong Y; Qin Y; Chen M
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881643
[TBL] [Abstract][Full Text] [Related]
3. Human Parainfluenza Virus Type 3 Matrix Protein Reduces Viral RNA Synthesis of HPIV3 by Regulating Inclusion Body Formation.
Zhang S; Cheng Q; Luo C; Qin Y; Chen M
Viruses; 2018 Mar; 10(3):. PubMed ID: 29534486
[TBL] [Abstract][Full Text] [Related]
4. Inclusion bodies of human parainfluenza virus type 3 inhibit antiviral stress granule formation by shielding viral RNAs.
Hu Z; Wang Y; Tang Q; Yang X; Qin Y; Chen M
PLoS Pathog; 2018 Mar; 14(3):e1006948. PubMed ID: 29518158
[TBL] [Abstract][Full Text] [Related]
5. PI4KB on Inclusion Bodies Formed by ER Membrane Remodeling Facilitates Replication of Human Parainfluenza Virus Type 3.
Li Z; Guo D; Qin Y; Chen M
Cell Rep; 2019 Nov; 29(8):2229-2242.e4. PubMed ID: 31747597
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
[TBL] [Abstract][Full Text] [Related]
7. The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.
Lingemann M; Surman S; Amaro-Carambot E; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2015 Mar; 89(6):3318-31. PubMed ID: 25589643
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
[TBL] [Abstract][Full Text] [Related]
9. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human parainfluenza virus type 3 infection by novel small molecules.
Mao H; Thakur CS; Chattopadhyay S; Silverman RH; Gudkov A; Banerjee AK
Antiviral Res; 2008 Feb; 77(2):83-94. PubMed ID: 17964670
[TBL] [Abstract][Full Text] [Related]
11. Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor.
Outlaw VK; Lemke JT; Zhu Y; Gellman SH; Porotto M; Moscona A
J Am Chem Soc; 2020 Feb; 142(5):2140-2144. PubMed ID: 31951396
[TBL] [Abstract][Full Text] [Related]
12. N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication.
Mao H; Chattopadhyay S; Banerjee AK
Virology; 2009 Nov; 394(1):143-8. PubMed ID: 19747707
[TBL] [Abstract][Full Text] [Related]
13. Virion-Associated Cholesterol Regulates the Infection of Human Parainfluenza Virus Type 3.
Tang Q; Liu P; Chen M; Qin Y
Viruses; 2019 May; 11(5):. PubMed ID: 31096557
[TBL] [Abstract][Full Text] [Related]
14. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins.
Skiadopoulos MH; Surman SR; Riggs JM; Orvell C; Collins PL; Murphy BR
Virology; 2002 May; 297(1):136-52. PubMed ID: 12083844
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.
Durbin AP; McAuliffe JM; Collins PL; Murphy BR
Virology; 1999 Sep; 261(2):319-30. PubMed ID: 10497117
[TBL] [Abstract][Full Text] [Related]
17. Bta-miR-98 Suppresses Replication of Caprine Parainfluenza Virus Type 3 Through Inhibiting Apoptosis by Targeting Caspase-3.
Li J; Zhong C; Liao Z; Mao L; Li W; Sun M; Liu M; Ji X; Liu C; Xue T; Yang L; Zhang W
Front Immunol; 2020; 11():1575. PubMed ID: 32983081
[TBL] [Abstract][Full Text] [Related]
18. Sumoylation of Human Parainfluenza Virus Type 3 Phosphoprotein Correlates with A Reduction in Viral Replication.
Cheng Q; Huai W; Wu X; Chen M
Virol Sin; 2021 Jun; 36(3):438-448. PubMed ID: 33197004
[TBL] [Abstract][Full Text] [Related]
19. A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.
Bailly JE; McAuliffe JM; Durbin AP; Elkins WR; Collins PL; Murphy BR
J Virol; 2000 Apr; 74(7):3188-95. PubMed ID: 10708435
[TBL] [Abstract][Full Text] [Related]
20. An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation.
Zhang S; Chen L; Zhang G; Yan Q; Yang X; Ding B; Tang Q; Sun S; Hu Z; Chen M
J Virol; 2013 Nov; 87(22):12457-70. PubMed ID: 24027324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
